Hamilton Lane Advisors’s Inhibikase Therapeutics IKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-13,802
| Closed | -$49.8K | – | 41 |
|
|
2023
Q2 | $49.8K | Sell |
13,802
-1
| -0% | -$4 | 0.02% | 50 |
|
|
2023
Q1 | $54.5K | Buy |
+13,803
| New | +$54.5K | 0.02% | 60 |
|
|
2022
Q4 | – | Sell |
-27,606
| Closed | -$151K | – | 72 |
|
|
2022
Q3 | $151K | Hold |
27,606
| – | – | 0.06% | 60 |
|
|
2022
Q2 | $123K | Hold |
27,606
| – | – | 0.05% | 67 |
|
|
2022
Q1 | $245K | Buy |
+27,606
| New | +$245K | 0.05% | 66 |
|